Evolent HealthEVH -0.52%66 9-Day RSI is 70.60 as of Jul. 05, 2026. GuruFocus rates EVH with a GF Score™ of 66/100 and a GF Value™ of $11.17 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Evolent Health ranks worse than 82.64% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-05), Evolent Health's 9-Day RSI is 70.60.
The industry rank for Evolent Health's 9-Day RSI or its related term are showing as below:
EVH's 9-Day RSI is ranked worse than 82.64% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 52.67
vs EVH: 70.60
Evolent Health (NYSE:EVH) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Evolent Health 9-Day RSI Related Terms
EVH vs PHR, CTEV, MDRX: 9-Day RSI Comparison
For the Health Information Services subindustry, Evolent Health's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Evolent Health's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (EVH) has a 9-Day RSI of 70.60 as of Jul. 05, 2026. According to the industry distribution chart, Evolent Health ranks #576 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 82.6%.
Is Evolent Health's 9-Day RSI too high?
Evolent Health's current 9-Day RSI is 70.60. The Healthcare Providers & Services industry median 9-Day RSI is 52.67. Evolent Health's value of 70.60 is 34% above this industry median. Based on the distribution chart, Evolent Health ranks #576 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Evolent Health has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's 9-Day RSI compare to PHR and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #576 out of 697 companies for 9-Day RSI. This places Evolent Health in the lower half of its industry. The industry median 9-Day RSI is 52.67. Evolent Health's value of 70.60 is 34% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 52.67, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current 9-Day RSI of 70.60 is 34% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 52.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current 9-Day RSI is 70.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.17, compared to a current price of $5.71 — trading 48.9% below its estimated fair value. The current 9-Day RSI is 70.60 and 34% above the Healthcare Providers & Services industry median of 52.67. Evolent Health's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Evolent Health (EVH), the current 9-Day RSI is 70.60 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.71 is trading 48.9% below its estimated GF Value™ of $11.17.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
9-Day RSI: 70.60
GF Value™: $11.17 vs. price of $5.71 (48.9% below fair value)
Industry Position: 34% above the Healthcare Providers & Services median (#576 of 697)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
66GF Score
Get the complete analysis for EVH
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 